CDT
Price:
$1.82
Market Cap:
$2.46M
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
Industry
Biotechnology
IPO Date
2022-03-28
Stock Exchange
NASDAQ
Ticker
CDT
According to CDT Equity Inc.’s latest financial reports and current stock price. The company's current ROE is -2194.54%. This represents a change of 1.73% compared to the average of -119.67% of the last 4 quarters.
The mean historical ROE of CDT Equity Inc. over the last ten years is -4327.12%. The current -2194.54% ROE has changed -49.28% with respect to the historical average. Over the past ten years (40 quarters), CDT's ROE was at its highest in in the March 2024 quarter at 115.23%. The ROE was at its lowest in in the December 2023 quarter at -389.28%.
Average
-4327.12%
Median
82.75%
Minimum
-17736.07%
Maximum
262.06%
Discovering the peaks and valleys of CDT Equity Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 141.68%
Maximum Annual ROE = 262.06%
Minimum Annual Increase = -100.27%
Minimum Annual ROE = -17736.07%
| Year | ROE | Change |
|---|---|---|
| 2024 | 262.06% | 123.86% |
| 2023 | 117.07% | 141.68% |
| 2022 | 48.44% | -100.27% |
The current ROE of CDT Equity Inc. (CDT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
142.52%
5-year avg
-4327.12%
10-year avg
-4327.12%
CDT Equity Inc.’s ROE is greater than Hepion Pharmaceuticals, Inc. (-1000.33%), less than Longevity Health Holdings Inc. (141.35%), less than ZyVersa Therapeutics, Inc. (677.15%), less than Envoy Medical, Inc. (108.32%), greater than SCWorx Corp. (-72.27%), greater than Lixte Biotechnology Holdings, Inc. (-308.56%), less than NewGenIvf Group Limited (3.44%), less than Petros Pharmaceuticals, Inc. (304.15%), less than Concord Medical Services Holdings Limited (7.22%), greater than Enveric Biosciences, Inc. (-341.49%),
| Company | ROE | Market cap |
|---|---|---|
| -1000.33% | $697.22K | |
| 141.35% | $548.98K | |
| 677.15% | $1.13M | |
| 108.32% | $17.59M | |
| -72.27% | $1.01M | |
| -308.56% | $19.34M | |
| 3.44% | $544.91K | |
| 304.15% | $373.92K | |
| 7.22% | $531.49K | |
| -341.49% | $3.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CDT Equity Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CDT Equity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CDT Equity Inc.'s ROE?
How is the ROE calculated for CDT Equity Inc. (CDT)?
What is the highest ROE for CDT Equity Inc. (CDT)?
What is the 3-year average ROE for CDT Equity Inc. (CDT)?
What is the 5-year average ROE for CDT Equity Inc. (CDT)?
How does the current ROE for CDT Equity Inc. (CDT) compare to its historical average?